Document is current
Any future updates will be listed below
-
Authors
Clarke, Erik
Chehoud, Christel
Khan, Najat
Spiessens, Bart
Poolman, Jan
Geurtsen, Jeroen
-
Funding
Funding for this research was provided by:
Janssen Research & Development
- License Information
-
More Information
Article History
Received: 7 November 2023
Accepted: 25 July 2024
First Online: 8 August 2024
Declarations
:
: Patient-level data extracted from the Optum® de-identified Electronic Health Record dataset were anonymous as per the US government’s Health Insurance Portability and Accountability Act (HIPAA) guidelines. The HIPAA Privacy Rule ensures the protection of individuals’ health information while allowing the necessary exchange of health information to inform medical research and promote high quality health care. Optum’s de-identification is under expert determination and there are no restrictions on the use or disclosure of de-identified health information. For more information on the HIPAA Privacy Rule, please visit . This study was conducted in compliance with the ethical principles of the Declaration of Helsinki and consistent with good clinical practice.
: The authors and Optum Pan-Therapeutic allow the editor to publish this work.
: EC, CC, NK, BS, JP, and JG are employees of Janssen.
